Gritstone Oncology is a privately-held cancer immunotherapy company developing next-generation personalized cancer therapeutics. Gritstone brings together distinguished scientific founders, an experienced and diverse management team, a seasoned and successful board of directors, and deep financial backing to tackle fundamental challenges at the intersection of cancer genomics, immunology, and immunotherapy design.
Market
Lung Cancer Treatment
Location
San Francisco,
CA,
USA
Coinvestors
Casdin Capital, Clarus Ventures, Frazier Healthcare, Redmile Group, The Column Group, Transformational Healthcare Opportunity, Versant Ventures